The pharmaceutical landscape for diabetes is shifting, and transdermal GLP-1 delivery systems represent a potential development. Unlike injections, this approach offers a less invasive way to provide GLP-1 therapies. https://mathelwum583957.bloguerosa.com/39666962/glp-1-patches-a-new-approach-to-glucose-treatment